NRX Pharmaceuticals, Inc. Proceeds from (Repayments of) Related Party Debt
NRX Pharmaceuticals, Inc. (NRXP) reported Proceeds from (Repayments of) Related Party Debt of -$176.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2023-03-31
- NRX Pharmaceuticals, Inc. proceeds from (repayments of) related party debt for the quarter ending 2021-12-31 was $1.00K.
- NRX Pharmaceuticals, Inc. proceeds from (repayments of) related party debt for fiscal 2021 was -$176.00K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 9 month as first filed | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$176.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$177.00K 10-Q · filed 2022-11-14 | -$176.47K 10-Q · filed 2021-11-15 | ||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | $100.00K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |